Finanzwire Finanzwire
Basculer en Français
10401 Companies
217373 Keywords
147002 Articles
115069 Press releases
Headlines Articles Press releases Clairvoyant Therapeutics Remove
  1. Home
  2. Companies
  3. Clairvoyant Therapeutics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/03/2024 at 14:05, 2 years 1 month ago

    Clairvoyant Therapeutics Advances Psilocybin Clinical Trial for Alcohol Use Disorder

    Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder Regulatory Pathway
  • PRESS RELEASE

    published on 04/03/2024 at 14:00, 2 years 1 month ago

    Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

    Clairvoyant Therapeutics aims to commercialize psilocybin treatment for alcohol use disorder by 2025. Company's trial progressing well, expecting results in 2024 & financing round underway
    Commercialization Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder
    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 11/29/2023 at 13:00, 2 years 5 months ago

    Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 03/20/2023 at 12:00, 3 years 1 month ago

    First Patient Dosed in Europe in Clairvoyant’s Phase 2b Clinical Trial Exploring Psilocybin Therapy as a Treatment for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
Accesswire
  • Published on 05/14/2026 at 00:00, 1 hour 52 minutes ago

    BEACN Announces Creation of Loan Program

  • Published on 05/13/2026 at 23:30, 2 hours 22 minutes ago

    CCL Industries Announces Results for 2026 First Quarter

  • Published on 05/13/2026 at 23:15, 2 hours 37 minutes ago

    Avino Delivers Record Q1 2026 Financial Results

  • Published on 05/13/2026 at 23:05, 2 hours 47 minutes ago

    Vox Royalty Reports Record Q1 2026 Results, Increases 2026 Guidance and Declares Quarterly Dividend

  • Published on 05/13/2026 at 22:30, 3 hours 22 minutes ago

    Amdocs Entitlement Server Sets New Industry Performance Benchmark on Microsoft Azure

View all ACCESSWIRE
EQS Group
  • Published on 05/14/2026 at 01:05, 46 minutes ago

    THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN

  • Published on 05/13/2026 at 22:20, 3 hours 31 minutes ago

    Rumble Announces Initial Results of Exchange Offer for Northern Data

  • Published on 05/13/2026 at 20:21, 5 hours 30 minutes ago

    Northern Data provides operational update

  • Published on 05/13/2026 at 20:18, 5 hours 33 minutes ago

    EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026

  • Published on 05/13/2026 at 19:28, 6 hours 23 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 05/13/2026 at 18:00, 7 hours 52 minutes ago

    DDV monthly statement at April 30 2026

  • Published on 05/13/2026 at 17:45, 8 hours 7 minutes ago

    Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.

  • Published on 05/13/2026 at 17:45, 8 hours 7 minutes ago

    Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026

  • Published on 05/13/2026 at 17:40, 8 hours 12 minutes ago

    Report on share repurchases from 6 to 12 May 2026

  • Published on 05/13/2026 at 16:00, 9 hours 52 minutes ago

    MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy